Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael D'Emden

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Diabetes Care|January 25, 2014
Do the new threshold levels for the diagnosis of gestational diabetes mellitus correctly identify women at risk?Michael d'Emden
Journal of Evaluation in Clinical Practice|April 23, 2013
Is the use of cholesterol in mortality risk algorithms in clinical guidelines valid? Ten years prospective data from the Norwegian HUNT 2 studyMichael d'Emden
The Australian & New Zealand Journal of Obstetrics & Gynaecology|December 23, 2011
Pregnancy-induced Cushing's syndrome in recurrent pregnancies: case report and literature reviewNaomi Achong, Michael D'Emden, Narelle Fagermo, et al.
Obstetric Medicine|September 16, 2016
Management of thyroid disease in pregnancy - Room for improvement in the first trimesterHelen Robinson, Philip Robinson, Michael D'Emden, et al.
Australian Prescriber|January 30, 2018
Thyroid disorders in pregnancy and postpartumAshleigh Smith, Jade Eccles-Smith, Michael D'Emden, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|September 4, 2025
The positive impact of a multidisciplinary preoperative diabetes clinic on improving glycaemic management in adults undergoing elective noncardiac surgeryAbby Yu, Karen Whitfield, Andrew Hale, et al.
Plos One|December 3, 2020
Development of a fasting blood glucose-based strategy to diagnose women with gestational diabetes mellitus at increased risk of adverse outcomes in a COVID-19 environmentMichael d'Emden, Donald McLeod, Jacobus Ungerer, et al.
Diabetes Care|June 28, 2006
Efficacy and safety of atorvastatin in the prevention of cardiovascular end points in subjects with type 2 diabetes: the Atorvastatin Study for Prevention of Coronary Heart Disease Endpoints in non-insulin-dependent diabetes mellitus (ASPEN)Robert H Knopp, Michael d'Emden, Johan G Smilde, et al.
Diabetes Research and Clinical Practice|December 3, 2017
SGLT2 inhibitors with cardiovascular benefits: Transforming clinical care in Type 2 diabetes mellitusMichael d'Emden, John Amerena, Gary Deed, et al.
Vascular Health and Risk Management|May 23, 2015
Lipid-modifying therapy in the elderlyIan Hamilton-Craig, David Colquhoun, Karam Kostner, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Diabetes Care|January 25, 2014
Do the new threshold levels for the diagnosis of gestational diabetes mellitus correctly identify women at risk?Michael d'Emden
Journal of Evaluation in Clinical Practice|April 23, 2013
Is the use of cholesterol in mortality risk algorithms in clinical guidelines valid? Ten years prospective data from the Norwegian HUNT 2 studyMichael d'Emden
The Australian & New Zealand Journal of Obstetrics & Gynaecology|December 23, 2011
Pregnancy-induced Cushing's syndrome in recurrent pregnancies: case report and literature reviewNaomi Achong, Michael D'Emden, Narelle Fagermo, et al.
Obstetric Medicine|September 16, 2016
Management of thyroid disease in pregnancy - Room for improvement in the first trimesterHelen Robinson, Philip Robinson, Michael D'Emden, et al.
Australian Prescriber|January 30, 2018
Thyroid disorders in pregnancy and postpartumAshleigh Smith, Jade Eccles-Smith, Michael D'Emden, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|September 4, 2025
The positive impact of a multidisciplinary preoperative diabetes clinic on improving glycaemic management in adults undergoing elective noncardiac surgeryAbby Yu, Karen Whitfield, Andrew Hale, et al.
Plos One|December 3, 2020
Development of a fasting blood glucose-based strategy to diagnose women with gestational diabetes mellitus at increased risk of adverse outcomes in a COVID-19 environmentMichael d'Emden, Donald McLeod, Jacobus Ungerer, et al.
Diabetes Care|June 28, 2006
Efficacy and safety of atorvastatin in the prevention of cardiovascular end points in subjects with type 2 diabetes: the Atorvastatin Study for Prevention of Coronary Heart Disease Endpoints in non-insulin-dependent diabetes mellitus (ASPEN)Robert H Knopp, Michael d'Emden, Johan G Smilde, et al.
Diabetes Research and Clinical Practice|December 3, 2017
SGLT2 inhibitors with cardiovascular benefits: Transforming clinical care in Type 2 diabetes mellitusMichael d'Emden, John Amerena, Gary Deed, et al.
Vascular Health and Risk Management|May 23, 2015
Lipid-modifying therapy in the elderlyIan Hamilton-Craig, David Colquhoun, Karam Kostner, et al.
Pageof 3